Switch to Unboosted Atazanavir With Tenofovir (SUAT) Study
Phase of Trial: Phase IV
Latest Information Update: 09 Jan 2017
At a glance
- Drugs Atazanavir (Primary) ; Atazanavir/ritonavir
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms SUAT
- 10 Jun 2017 Biomarkers information updated
- 09 Jan 2017 Primary endpoint (Proportion of subjects without treatment failure at 48 weeks) has not been met, according to results published in the HIV Clinical Trials Journal.
- 09 Jan 2017 Results published in the HIV Clinical Trials Journal.